These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 19958120)
1. Robo1: a potential role in ocular angiogenesis. Huang L; Xu Y; Yu W; Li X; Liqun C; He X; Peiying H Curr Eye Res; 2009 Dec; 34(12):1019-29. PubMed ID: 19958120 [TBL] [Abstract][Full Text] [Related]
2. Effect of Robo1 on retinal pigment epithelial cells and experimental proliferative vitreoretinopathy. Huang L; Xu Y; Yu W; Li Y; Chu L; Dong J; Li X Invest Ophthalmol Vis Sci; 2010 Jun; 51(6):3193-204. PubMed ID: 20071679 [TBL] [Abstract][Full Text] [Related]
3. Robo1/robo4: different expression patterns in retinal development. Huang L; Yu W; Li X; Niu L; Li K; Li J Exp Eye Res; 2009 Mar; 88(3):583-8. PubMed ID: 19084519 [TBL] [Abstract][Full Text] [Related]
4. Expression of Robo4 in the fibrovascular membranes from patients with proliferative diabetic retinopathy and its role in RF/6A and RPE cells. Huang L; Yu W; Li X; Xu Y; Niu L; He X; Dong J; Yan Z Mol Vis; 2009 May; 15():1057-69. PubMed ID: 19495426 [TBL] [Abstract][Full Text] [Related]
5. Localization of VEGF receptor-2 (KDR/Flk-1) and effects of blocking it in oxygen-induced retinopathy. McLeod DS; Taomoto M; Cao J; Zhu Z; Witte L; Lutty GA Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):474-82. PubMed ID: 11818393 [TBL] [Abstract][Full Text] [Related]
6. Suppression of ICAM-1 in retinal and choroidal endothelial cells by plasmid small-interfering RNAs in vivo. Hirano Y; Sakurai E; Matsubara A; Ogura Y Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):508-15. PubMed ID: 19578010 [TBL] [Abstract][Full Text] [Related]
7. SB-267268, a nonpeptidic antagonist of alpha(v)beta3 and alpha(v)beta5 integrins, reduces angiogenesis and VEGF expression in a mouse model of retinopathy of prematurity. Wilkinson-Berka JL; Jones D; Taylor G; Jaworski K; Kelly DJ; Ludbrook SB; Willette RN; Kumar S; Gilbert RE Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1600-5. PubMed ID: 16565398 [TBL] [Abstract][Full Text] [Related]
8. Functionally defining the endothelial transcriptome, from Robo4 to ECSCR. Verissimo AR; Herbert JM; Heath VL; Legg JA; Sheldon H; Andre M; Swain RK; Bicknell R Biochem Soc Trans; 2009 Dec; 37(Pt 6):1214-7. PubMed ID: 19909249 [TBL] [Abstract][Full Text] [Related]
9. Herbimycin A inhibits angiogenic activity in endothelial cells and reduces neovascularization in a rat model of retinopathy of prematurity. McCollum GW; Rajaratnam VS; Bullard LE; Yang R; Penn JS Exp Eye Res; 2004 May; 78(5):987-95. PubMed ID: 15051479 [TBL] [Abstract][Full Text] [Related]
11. Targeting of integrin-linked kinase with small interfering RNA inhibits VEGF-induced angiogenesis in retinal endothelial cells. Xie W; Zhao M; Zhou W; Guo L; Huang L; Yu W; Li X Ophthalmic Res; 2013; 49(3):139-49. PubMed ID: 23258222 [TBL] [Abstract][Full Text] [Related]
12. Impact of triamcinolone acetonide on retinal endothelial cells in a retinopathy of prematurity mouse model. Akkoyun I; Yilmaz G; Oto S; Kahraman B; Haberal N; Akova YA Acta Ophthalmol Scand; 2007 Nov; 85(7):791-4. PubMed ID: 17488319 [TBL] [Abstract][Full Text] [Related]
13. Aquaporin-1 independent microvessel proliferation in a neonatal mouse model of oxygen-induced retinopathy. Ruiz-Ederra J; Verkman AS Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4802-10. PubMed ID: 17898307 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of oxygen-induced retinopathy in RTP801-deficient mice. Brafman A; Mett I; Shafir M; Gottlieb H; Damari G; Gozlan-Kelner S; Vishnevskia-Dai V; Skaliter R; Einat P; Faerman A; Feinstein E; Shoshani T Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3796-805. PubMed ID: 15452091 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of pathologic retinal neovascularization by a small peptide derived from human apolipoprotein(a). Zhao H; Jin H; Li Q; Gu Q; Zheng Z; Wu H; Ye S; Sun X; Xu X; Ho PC Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5384-95. PubMed ID: 19515999 [TBL] [Abstract][Full Text] [Related]
16. Fractalkine, a CX3C chemokine, as a mediator of ocular angiogenesis. You JJ; Yang CH; Huang JS; Chen MS; Yang CM Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5290-8. PubMed ID: 17962485 [TBL] [Abstract][Full Text] [Related]
17. AMG 386, a selective angiopoietin 1/2-neutralizing peptibody, inhibits angiogenesis in models of ocular neovascular diseases. Oliner JD; Bready J; Nguyen L; Estrada J; Hurh E; Ma H; Pretorius J; Fanslow W; Nork TM; Leedle RA; Kaufman S; Coxon A Invest Ophthalmol Vis Sci; 2012 Apr; 53(4):2170-80. PubMed ID: 22410553 [TBL] [Abstract][Full Text] [Related]
18. Potential anti-angiogenic role of Slit2 in corneal neovascularization. Han X; Zhang MC Exp Eye Res; 2010 Jun; 90(6):742-9. PubMed ID: 20298689 [TBL] [Abstract][Full Text] [Related]